1,798
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Adherence to Mediterranean diet and risk of prostate cancer

, , , , , , ORCID Icon, & show all
Pages 102-108 | Received 06 Jan 2018, Accepted 07 Mar 2018, Published online: 15 Mar 2018

Abstract

In Europe, countries following the traditional Mediterranean Diet (MeDi), particularly Southern European countries, have lower prostate cancer (PCa) incidence and mortality compared to other European regions. In the present study, we investigated the association between the MeDi and the relative risk of PCa and tumor aggressiveness in a Spanish population. Among individual score components, it has been found that subjects with PCa were less likely to consume olive oil as the main culinary fat, vegetables, fruits and fish than those without. However, these differences were not statistically significative. A high intake of fruit, vegetables and cooked tomato sauce Mediterranean style (sofrito) was related to less PCa aggressiveness. Results showed that there are no differences in the score of adherence to the Mediterranean dietary patterns between cases and controls, with mean values of 8.37 ± 1.80 and 8.25 ± 2.48, respectively. However, MeDi was associated with lower PCa agressiveness according to Gleason score. Hence, relations between Mediterranean dietary patterns and PCa are still inconclusive and merit further investigations. Further large-scale studies are required to clarify the effect of MeDi on prostate health, in order to establish the role of this diet in the prevention of PCa.

Introduction

Prostate cancer (PCa) is the second most common cancer in men, with nearly a million new cases diagnosed world-wide per year [Citation1–3]. Diet, lifestyle, environmental and genetic factors are hypothesized to play a role in these differences [Citation2]. In Europe, countries following the traditional Mediterranean Diet (MeDi), particularly Southern European countries, have lower PCa incidence and mortality compared to other European regions [Citation4]. The general features of this diet are high intake of vegetables, fruits, nuts, legumes, cereals and lean fish, moderate consumption of alcohol and low amounts of milk and read meat. Several of these individual food items, or the nutrients they contain, have been associated with a reduced risk of prostate cancer [Citation5]. Trichopoulou et al. [Citation6] calculated that 10% of the incidence of PCa could be prevented if the populations of highly developed Western countries could shift to the traditional healthy MeDi.

There are a few studies that have assessed the effect of the MeDi on cancer prostate incidence in non-Mediterranean population. The European Prospective Investigation into Cancer and Nutrition (EPIC) study showed that a MeDi is particularly beneficial in protecting against PCa [Citation7]. Schwingshackl and Hoffmann [Citation8] in a recent meta-analysis showed that high adherence to a MeDi is associated with a significant 4% reduction in the risk of PC. Kenfield et al. [Citation9] described that adherence to a MeDi evaluated through a MeDi Score was not associated with risk of advanced PCa or disease progression in a prospective study following 47,867 US men. However, greater adherence to the MeDi after diagnosis of nonmetastatatic cancer was associated with lower overall mortality. Bosire et al. [Citation10] report no relationship between the alternate Mediterranean diet score diet and the risk of PCa in the National Institutes of Health (NIH)-AARP Diet and Health Study cohort (293,464 US men). In addition, it was found little support for an association between the MeDi and PCa in two Northern European case-control study [Citation5,Citation11]. In a recent study, Erdrich et al. [Citation12] carried out a small pilot study in which 20 men with diagnosed PCa adhered to a MeDi. A significant reduction in DNA damage compared to baseline was apparent, with particular benefit noted for overall adherence to the diet (p = .013), ostensibly due to reduction in reactive oxidant species. There is only one study carried out in Mediterranean population that explores the association of the Mediterranean dietary pattern with PCa risk. Castelló et al. [Citation13] showed that a Mediterranean dietary pattern is associated to lower risk of aggressive PCa in a Spanish population. This association was not observed with Prudent pattern, which combines vegetables and fruits with low-fat dairy products, whole grains and juices [Citation13]. Due to the contradiction between the studies, the impact of MeDi adherence on prostate health remains unclear.

In the present study, we investigated the association between the MeDi and the relative risk of PCa and tumor aggressiveness in a Spanish population. To the best of our knowledge, this is the first study specifically investigating PCa risk and the MeDi using a score in Spain.

Materials and methods

Patients and data collection

Patient recruitment was carried out in the Department of Urology, University Hospital “Virgen de las Nieves”, Granada. Research protocols were approved by the Institutional Review Boards at the Hospital. All men enrolled in the study were patients with PSA levels above 4 ng/ml with a suspicion of developing PCa and upon whom a biopsy was performed. After the analysis of the Anatomy Pathology, subjects were classified in patients (n = 254) and controls (n = 302). Informed consents were required from all participants in the trial, and the study has been approved by local institutional review boards and Ethics Committees and conducted in accordance with the Declaration of Helsinki.

Consented patients were interviewed by the urologists and were asked to respond to a series of structured questionnaires that solicited information, which included background characteristics, occupation, family history of PCa, comorbid conditions, PCa diagnosis and physical activity level. At the time of interview subjects, height was measured using a stadiometer and weight was measured using a floor scale. BMI was then calculated using the formula weight (Kg)/height (m)2.

Clinical parameters

PCa characteristics, which included Gleason grade and serum PSA level, were obtained by the urologists. PCa aggressiveness was classified as a function of Gleason grading system. The Gleason score grades the severity of prostate tumors according to tumor histology. PCa with a total Gleason score ≥7 was considered histologically aggressive; while those graded <7 were regarded nonaggressive [Citation14].

Nutritional survey

The Mediterranean Diet Score (MDS), a validated MeDi questionnaire [Citation15] was completed in a face-to-face interview with participants by specifically trained dieticians. The questionnaire assessed the consumption of elements included in the MeDi (olive oil, wine, fruits, vegetables, fish, legumes and whole-grain intake). A low consumption of meat or meat products, butter, margarine or cream, carbonated beverages and commercial sweet or pastries were also included in the composite score questionnaire [Citation15].

Statistical methods

SPSS v.20.0 (SPSS Inc., Chicago, IL) was used for statistical analysis. Chi-square and Fisher’s test was used to evaluate the differences in distribution of categorical variables. Shapiro–Wilk’s test was performed to check the normality of the variables.

The analysis of the relation of MeDi and PCa risk and aggressiveness was performed by means of binary logistic regression analysis. Potential confunders were included, like age and family history of PCa. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated.

Results and discussion

The study population is described in . The cases were somewhat older than the controls and were more likely to be employed in agricultural work and to have a family history of PCa. Nutritional status revealed that 52.3% of cases were overweight and 27.9% were obese versus only 19.8% patients with an adequate BMI. There were no major differences between cases and controls concerning BMI, smoking status, physical activity and coffee intake.

Table 1. Sociodemographic characteristics of case and control participants.

Exposure to inadequate diets through life may influence PCa progression due to the long pre-clinical stage [Citation16]. Schwingshackl and Hoffmann in a meta-analysis [Citation8] have confirmed the concept that a high adherence to the MeDi was associated with a significant reduction in both mortality and cancer incidence by 10% (RR: 0.90, 95% CI 0.86–0.95, p < .0001). In particular, the authors assessed that the risk of PCa could be reduced by 4% with a high adherence to MeDi. In their review, the authors confirmed both the concept that dietary factors could reduce cancer risk through several mechanisms, involving the suppression of spontaneous mutations of DNA, the modulation of cell proliferation, or the methylation of DNA and the induction of apoptosis. Schwingshackl and Hoffmann also reiterated the highly protective role of the olive oil, which is one of the main components of the MeDi.

In this study, the percentage of achievement of the specific MeDi items was compared according to the biopsy results (). It has been found that subjects with PCa were less likely to consume olive oil as the main culinary fat (98.5% vs. 100%), vegetables (48.57% vs. 50.66%), fruits (58.57% vs. 61.33%) and fish (49.32% vs. 50.30%) than those without. On the contrary, cases consume more quantity of meat product, butter and carbonated beverages. However, these differences were not statistically significative.

Table 2. Individual components of Mediterranean diet score and prostate cancer risk.

Olive oil is the major common characteristic of diet in Mediterranean populations, where it accounts for one to two-thirds of total vegetable fat intake and is therefore a relevant source not only of unsaturated fats, but of several other dietary components and micronutrients, as well. An Australian case-control study compared subjects consuming <0.25 and ≥0.25 l/month to nonusers of olive oil, and reported no significant association between olive oil consumption and PCa risk (both ORs =0.8) [Citation17]. In a population-based case–control study was conducted in New Zealand increasing levels of MUFA-rich vegetable oil intake were associated with a progressive reduction in PCa risk [Relative risk (RR) = 0.5; 95% CI: 0.3–0.9; > 5.5 ml per day vs. nonconsumption, p = .005] [Citation18]. However, PCa risk was not associated with intake of total MUFA or its major animal food sources. Fruits and vegetables contain numerous components known to have favorable effects on inflammatory, cellular redox, as well as metabolic processes and endothelial function, which might add up to their tumor-protective impact. In addition, regular consumption of fruits and vegetables facilitates weight management in overweight subjects to counter obesity as a risk factor for cancer [Citation19]. The obesity has been related with the oxidative stress and the mitochondrial dysfunction. In fact, mitochondrial DNA mutations have been found to play a role in the genesis of numerous cancers [Citation20] A meta-analysis from 12 case–control studies (5777 cases and 9805 control) and from 12 cohort studies (445,820 subjects), concerning fish intake and the incidence and mortality of PCa [Citation1,Citation21], did not observe any significant association between fish consumption and a reduction of PCa incidence among cohort studies (RR: 1.01; 95% CI: 0.90–1.14; p = .83). Authors observed a weak association between fish intake and reduction of PCa incidence from case–control studies (RR: 0.85; 95% CI: 0.72–1.00; p = .05) ().

Table 3. Individual components of Mediterranean diet score and prostate cancer aggressiveness.

One of the potential reasons for inconsistent results of epidemiological studies examining the association between MeDi and PCa may be that most of the studies had a small number of advanced tumors [Citation22]. Potential associations between different components of the MeDi and prostate tumor aggressiveness (Gleason score ≥7) were explored. Among individual score components, a high intake of fruit, vegetables and cooked tomato sauce Mediterranean style (sofrito) is related to less aggressiveness. However, there are controversial points of the effect of MeDi focuses on testosterone therapy in Pca men [Citation23]. MeDi could contribute to elevate testosterone levels and the testosterone replacement therapy has a protective role against high-grade PCa [Citation24,Citation25] with no difference in overall mortality and incidence of PCa progression, in both, intermittent hormone therapy and continuous hormone therapy [Citation26]. These observations are in agreement with the fact that PCa men, who are receive androgen deprivation treatment, are classified at risk of developing insulin resistance and hyperglycemia, which leads them to an increased risk of cardiovascular diseases [Citation27].

Mediterranean sofrito is a key component of the MeDi, provides nutritional interest due to its high content in bioactive compounds from garlic and onion such as isoflavone, tomato such as lycopene and olive oil, and especially to the lipid matrix in which these compounds are found [Citation28,Citation29]. Studies have shown that plasma steroid hormones have been implicated in the development of the benign prostatic hyperplasia and PCa [Citation30]. The genistein, a soy phytoestrogen, is involved in the estrogen and androgen signaling pathways and may protect against PCa [Citation31]. Lycopene is the pigment principally responsible for the characteristic deep-red color of tomato products. Peisch et al. [Citation32] suggested that several dietary factors, such as tomato sauce/lycopene and vegetables may have a role in reducing risk of PCa progression. Recently, it has been found that the presence of other ingredients in Mediterranean sofrito such as extra virgin olive oil, onion and garlic improve the bioavailability of lycopene [Citation33]. In addition, it was observed that the plasma concentration of lycopene significantly increased after the consumption of tomatoes meal cooked in olive oil, compared to the consumption of tomatoes meals cooked without olive oil [Citation34]. Some studies have hypothesized that the consumption of a diet rich in lycopene-containing foods reduces the aggressive potential of PCa by inhibiting the neoangiogenesis that occurs in tumor development [Citation35]. The main role of lycopene seems to be related to producing a modulation in redox activity, enzyme detoxification, inhibition of cell proliferation and apoptosis induction [Citation36]. Recent studies have proved that lycopene increased the amount of some protective enzymes, such as glutathione-S-transferase-omega-1, peroxiredoxin-1 and sulfide-quinone oxidoreductase. Proteins, such as ERO1-like protein-α or CLIC-1, usually involved in reactive oxygen species generation, have been shown to be downregulated after treatment with lycopene. This indicates a potential for lycopene to lower the risk for the generation of reactive oxygen species and to reduce oxidative stress [Citation37]. Most case–control studies have demonstrated a significant, inverse association between intakes of vegetables and the risk of advanced prostate cancer, with risk estimates (ORs) ranged from 0.36 to 0.96 [Citation38,Citation39]. However, no association was found between intake of vegetables and the risk of advanced prostate cancer in most cohort studies [Citation40,Citation41]. Similarly, fruit intake was overall not associated with the risk of advanced prostate cancer in both case–control [Citation38,Citation42] and cohort studies [Citation41].

showed that there are no differences in the score of adherence to the Mediterranean dietary patterns between cases and controls, with mean values of 8.37 ± 1.80 and 8.25 ± 2.48, respectively. These results are in agreement with previous studies that found no significant association between MeDi pattern and PCa risk [Citation5,Citation9–11,Citation13]. These results might be affected by the blunt scoring method, which is insufficient to consider all dietary factors, or by counter-balancing the protective or promoting effect of each component when combined together [Citation3]. It should be taken into account that is difficult to compare the studies accurately, and the possibility of a controversial outcome is higher. The differences between studies include the following: diverse versions or modifications of indices; various index components; scoring methods and categorization criteria [Citation3]. Finally, most of the studies were conducted in North Europe and North America, indicating that the populations involved in the studies are relatively similar. Therefore, further studies should be conducted actively in Mediterranean population from different countries.

Table 4. Mediterranean diet score and PC risk and aggressiveness.

There is an inverse association between MDS and risk of aggressive tumors according to Gleason score (). These results are in agreement with several studies in which a protective effect of dietary patterns with high consumption of fruits and vegetables, fish and olive oil for aggressive tumors has been described [Citation13,Citation43–45]. In addition, with those diagnosed with nonmetastatic PCa at baseline, adherence to the MeDi was associated with lower overall mortality, suggesting possible beneficial effects [Citation9]. In contrast, Mehdad and coworkers [Citation16] found no association between diet and tumor aggressiveness (Gleason score > =7).

In conclusion, there are few studies that have assessed the effect of the MeDi on cancer prostate incidence, specially in Mediterranean population. Recent data do not support associations to adherence to a MeDi and risk of PCa. However, Mediterranean eating pattern was associated with lower PCa agressiveness. Hence, relations between Mediterranean dietary patterns and PCa are still inconclusive and merit further investigations. Further large-scale studies are required to clarify the effect of MeDi on prostate health, in order to establish the role of this diet in the prevention of PCa.

Acknowledgements

This paper will be part of Noelia Urquiza’s and Manrique Pascual-Geler´s doctorates which are being completed as part of the Doctorate Program in Pharmacy and in Nutrition and Food Science, respectively, at the University of Granada, Spain.

Disclosure statement

No potential conflict of interest was reported by the authors. This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

References

  • Capurso C, Vendemiale G. The Mediterranean diet reduces the risk and mortality of the prostate cancer: a narrative review. Front Nutr. 2017;4:38.
  • Lin PH, Aronson W, Freedland SJ. Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med. 2015;13:3.
  • Kim JH, Kim J. Index-based dietary patterns and the risk of prostate cancer. Clin Nutr Res. 2017;6:229–246.
  • Bray F, Lortet-Tieulent J, Ferlay J, et al. Prostate cancer incidence and mortality trends in 37 European countries: An overview. Eur J Cancer. 2010;46:3040–3052.
  • Möller E, Galeone C, Andersson TM, et al. Mediterranean diet score and prostate cancer risk in a swedish population-based case–control study. J Nutr Sci. 2013;2:e15.
  • Trichopoulou A, Lagiou P, Kuper H, et al. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000;9:869–873.
  • Couto E, Boffetta P, Lagiou P, et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer. 2011;104:1493–1499.
  • Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer. 2014;135:1884–1897.
  • Kenfield SA, DuPre N, Richman EL, et al. Mediterranean diet and prostate cancer risk and mortality in the health professionals follow-up study. Eur Urol. 2014;65:887–894.
  • Bosire C, Stampfer MJ, Subar AF, et al. Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol. 2013;177:504–513.
  • Ax E, Garmo H, Grundmark B, et al. Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of swedish men. Nutr Cancer. 2014;66:77–87.
  • Erdrich S, Bishop KS, Karunasinghe N, et al. A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet. Peer J. 2015;3:e1080
  • Castelló A, Boldo E, Amiano P, et al. Mediterranean dietary pattern is associated with low risk of aggressive prostate cancer: MCC-Spain Study. J Urol. 2018;199:430–437.
  • Montironi R, Santoni M, Mazzucchelli R, et al. Prostate cancer: from Gleason scoring to prognostic grade grouping. Expert Rev Anticancer Ther. 2016;16:433–440.
  • Martínez-González MA, García-Arellano A, Toledo E, et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One. 2012;7:e43134.
  • Mehdad A, Mcbride E, Monteiro Grillo I, et al. Nutritional status and eating pattern in prostate cancer patients. Nutr Hosp. 2010;25:422–427.
  • Hodge AM, English DR, McCredie MR, et al. Foods, nutrients and prostate cancer. Cancer Causes Control. 2004;15:11–20.
  • Norrish AE, Jackson RT, Sharpe SJ, et al. Men who consume vegetable oils rich in monounsaturated fat: their dietary patterns and risk of prostate cancer (New Zealand). Cancer Causes Control. 2000;11:609–615.
  • Schwingshackl L, Schwedhelm C, Galbete C, et al. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients. 2017;9. DOI:10.3390/nu9101063
  • Canto P, Benítez Granados J, Martínez Ramírez MA, et al. Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity. Aging Male. 2016;19:187–191.
  • Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–1233.
  • Pascual-Geler M, Urquiza-Salvat N, Cozar JM, et al. The influence of nutritional factors on prostate cancer incidence and aggressiveness. Aging Male. 2017;20:1–9.
  • Morgentaler A, Zitzmann M, Traish AM, et al. International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. Aging Male. 2015;18:205–206.
  • Yassin A, Salman M, Talib RA, et al. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male. 2017;20:125–133.
  • Efesoy O, Apa D, Tek M, et al. The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. Aging Male. 2016;19:79–84.
  • Dong Z, Wang H, Xu M, et al. Intermittent hormone therapy versus continuous hormone therapy for locally advanced prostate cancer: a meta-analysis. Aging Male. 2015;18:233–237.
  • Haidar A, Yassin A, Saad F, et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007;10:189–196.
  • Rodriguez-Rodriguez R, Jiménez-Altayó F, Alsina L, et al. Mediterranean tomato-based sofrito protects against vascular alterations in obese Zucker rats by preserving NO bioavailability. Mol Nutr Food Res. 2017;61(9). DOI:10.1002/mnfr.201601010.
  • Morgia G, Castelli T, Privitera S, et al. Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily. Aging Male. 2017;17:1–7.
  • Grosman H, Fabre B, Lopez M, et al. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease. Aging Male. 2016;19:40–45.
  • Russo GI, Di Mauro M, Regis F, et al. Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily. Aging Male. 2017;17:1–7.
  • Peisch SF, Van Blarigan EL, Chan JM, et al. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017;35:867–874.
  • Rinaldi de Alvarenga JF, Tran C, Hurtado-Barroso S, et al. Home cooking and ingredient synergism improve lycopene isomer production in Sofrito. Food Res Int. 2017;99:851–861.
  • Fielding JM, Rowley KG, Cooper P, et al. Increases in plasma lycopene concentration after consumption of tomatoes cooked with olive oil. Asia Pac J Clin Nutr. 2005;14:131–136.
  • Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014;106:djt430.
  • Kolberg M, Pedersen S, Bastani NE, et al. Tomato paste alters NF-κB and cancer-related mRNA expression in prostate cancer cells,xenografts, and xenograft microenvironment. Nutr Cancer. 2015;67:305–315.
  • Holzapfel NP, Holzapfel BM, Champ S, et al. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. IJMS. 2013;14:14620–14646.
  • Hardin J, Cheng I, Witte JS. Impact of consumption of vegetable, fruit, grain, and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer. 2011; 63:860–872.
  • Kolonel LN, Hankin JH, Whittemore AS, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev. 2000;9:795–804.
  • Agalliu I, Kirsh VA, Kreiger N, et al. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiol. 2011;35:353–361.
  • Takachi R, Inoue M, Sawada N, et al. Fruits and vegetables in relation to prostate cancer in Japanese men: the Japan Public Health Center-Based Prospective Study. Nutr Cancer. 2010; 62:30–39.
  • Amin M, Jeyaganth S, Fahmy N, et al. Dietary habits and prostate cancer detection: a case-control study. Can Urol Assoc J. 2008;2:510–515.
  • Ambrosini GL, Fritschi L, de Klerk NH, et al. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia. Ann Epidemiol. 2008;18:364–370.
  • Muller DC, Severi G, Baglietto L, et al. Dietary patterns and prostate cancer risk. Cancer. Epidemiol Biomarkers Prev. 2009;18:3126–3129.
  • Tantamango-Bartley Y, Knutsen SF, Knutsen R, et al. Are strict vegetarians protected against prostate cancer? Am J Clin Nutr. 2016;103:153–160.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.